CI vs EBS
Cigna Corp (CI) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CI and EBS stock pages for the full models.
Not investment advice.